MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-23-2026
Integer Holdings Corporation Total Liabilities 2011-2026 | ITGR
Annual Total Liabilities Integer Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.66 B | 1.46 B | 1.42 B | 1.38 B | 1.23 B | 1.1 B | 1.2 B | 1.27 B | 1.95 B | 2.13 B | 342 M | 349 M | - | 409 M | 414 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.13 B | 342 M | 1.17 B |
Quarterly Total Liabilities Integer Holdings Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.65 B | 1.67 B | 1.69 B | 1.46 B | 1.55 B | 1.57 B | 1.59 B | 1.42 B | 1.38 B | 1.42 B | 1.46 B | 1.38 B | 1.38 B | - | 1.24 B | 1.23 B | 1.02 B | 1.04 B | 1.07 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.27 B | 1.27 B | 1.27 B | 1.27 B | 1.95 B | 1.95 B | 1.95 B | 1.95 B | 2.11 B | 2.11 B | 2.11 B | 2.11 B | 342 M | 338 M | 325 M | 318 M | 349 M | 334 M | 328 M | 324 M | - | 360 M | 394 M | 396 M | 409 M | 409 M | 409 M | 409 M | 414 M | 414 M | 414 M | 414 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.11 B | 318 M | 1.1 B |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
82 M | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 38.89 | -0.97 % | $ 5.8 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
281 M | $ 8.15 | 4.28 % | $ 585 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 9.67 | 2.87 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.15 | 4.01 % | $ 155 M |  France |
 |
Electromed
ELMD
|
10.6 M | $ 24.4 | 1.73 % | $ 206 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 43.12 | -0.45 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.53 | 0.16 % | $ 121 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
92.8 M | $ 29.26 | -1.91 % | $ 1.35 B | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.34 | 5.36 % | $ 116 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
389 M | $ 0.52 | -0.82 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
20 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.79 | -1.75 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 182.04 | -0.33 % | $ 13.6 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
87.2 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.05 | 9.32 % | $ 857 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 113.39 | -0.17 % | $ 197 B | USA |
 |
NuVasive
NUVA
|
970 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
323 M | - | - | $ 217 M | USA |
 |
InMode Ltd.
INMD
|
83.2 M | $ 13.53 | -0.51 % | $ 874 M | Israel |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 72.94 | -1.23 % | $ 108 B | USA |
 |
IRadimed Corporation
IRMD
|
11.5 M | $ 105.07 | 0.75 % | $ 1.33 B | USA |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.35 | 18.43 % | $ 1.43 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 13.05 | 0.19 % | $ 1.96 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 85.52 | 0.3 % | $ 50 B | USA |